Basic Information
| LncRNA/CircRNA Name | SANT1 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | renal cell carcinoma |
| ICD-0-3 | C64.9 |
| Methods | qPCR, Western blot |
| Sample | RCC tissue,cell lines (786-O, 769-P, ACHN,Caki-1,) |
| Expression Pattern | down-regulated |
| Function Description | Similar to the SLC47A2 mRNA level, SANT1 was downregulated in RCC |
| Pubmed ID | 30951404 |
| Year | 2019 |
| Title | A novel human lncRNA SANT1 cis-regulates the expression of SLC47A2 by altering SFPQ/E2F1/HDAC1 binding to the promoter region in renal cell carcinoma. |
External Links
| Links for SANT1 | GenBank HGNC NONCODE |
| Links for renal cell carcinoma | OMIM COSMIC |